Molecular Therapy · 2010 · 82 citations · 21 references
PharmacyBiotechnologyDermatologyDrug DeliveryGene DeliveryGene ExpressionGene Delivery SystemsGene Delivery VectorsLocal Gene DeliveryMicroneedle-based DeliveryNucleic Acid DeliverySmall Interfering Rna DeliveryGene Delivery CarriersGene Silencing Delivery SystemsLuciferase ReportersMicroneedle Delivery SystemsSkin Barrier PenetrationTargeted Gene ExpressionTargeted Gene SilencingTransgenic Mouse Models
Despite rapid progress in the development of potent and selective small interfering RNA (siRNA) agents for skin disorders, translation to the clinic has been hampered by the lack of effective, patient-friendly delivery technologies. The stratum corneum poses a formidable barrier to efficient delivery of large and/or charged macromolecules including siRNAs. Intradermal siRNA injection results in effective knockdown of targeted gene expression but is painful and the effects are localized to the injection site. The use of microneedle arrays represents a less painful delivery method and may have utility for the delivery of nucleic acids, including siRNAs. For this purpose, we developed a loadable, dissolvable protrusion array device (PAD) that allows skin barrier penetration. The PAD tips dissolve upon insertion, forming a gel-like plug that releases functional cargo. PAD-mediated delivery of siRNA (modified for enhanced stability and cellular uptake) resulted in effective silencing of reporter gene expression in a transgenic reporter mouse model. PAD delivery of luciferase reporter plasmids resulted in expression in cells of the ear, back, and footpad skin as assayed by intravital bioluminescence imaging. These results support the use of PADs for delivery of functional nucleic acids to cells in the skin with an efficiency that may support clinical translation. Despite rapid progress in the development of potent and selective small interfering RNA (siRNA) agents for skin disorders, translation to the clinic has been hampered by the lack of effective, patient-friendly delivery technologies. The stratum corneum poses a formidable barrier to efficient delivery of large and/or charged macromolecules including siRNAs. Intradermal siRNA injection results in effective knockdown of targeted gene expression but is painful and the effects are localized to the injection site. The use of microneedle arrays represents a less painful delivery method and may have utility for the delivery of nucleic acids, including siRNAs. For this purpose, we developed a loadable, dissolvable protrusion array device (PAD) that allows skin barrier penetration. The PAD tips dissolve upon insertion, forming a gel-like plug that releases functional cargo. PAD-mediated delivery of siRNA (modified for enhanced stability and cellular uptake) resulted in effective silencing of reporter gene expression in a transgenic reporter mouse model. PAD delivery of luciferase reporter plasmids resulted in expression in cells of the ear, back, and footpad skin as assayed by intravital bioluminescence imaging. These results support the use of PADs for delivery of functional nucleic acids to cells in the skin with an efficiency that may support clinical translation.
21
Dissolving microneedles for transdermal drug delivery
Jeong Woo Lee, Jung‐Hwan Park, Mark R. Prausnitz · Biomaterials · 2008 · 942 citations · Full text
Effect of Microneedle Design on Pain in Human Volunteers
Harvinder Singh Gill, Donald D. Denson, Brett A. Burris et al. · Clinical Journal of Pain · 2008 · 681 citations · Full text
Designing siRNA That Distinguish between Genes That Differ by a Single Nucleotide
Dianne S. Schwarz, Hongliu Ding, Lori Kennington et al. · PLoS Genetics · 2006 · 275 citations · Full text